Atlas Trials

A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease

Clinical trial NCT04804540 · COMPLETED

Trial details

NCT number
NCT04804540
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative ColitisCrohn Disease
Start date
2021-12-08
Primary completion
2024-02-02
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.